Overnight Correction Opportunity to expand into eye care providers and clinics offering orthokeratology solutions, leveraging Euclid Systems' Max orthokeratology lens to attract patients seeking non-surgical myopia management.

Strategic Partnerships Target collaboration with large ophthalmic players and distributors (similar to CooperVision and Alcon scale) to accelerate market reach for sustained delivery drug delivery system and orthokeratology products.

China Market leverage leadership additions in marketing and manufacturing to accelerate penetration in China, tapping a significant growth market for premium orthokeratology lenses and ophthalmic therapeutics.

Premium Ophthalmics Position Euclid as a high-end ophthalmic innovator with advanced materials and sustained delivery platforms, appealing to clinics and hospitals seeking differentiated care and long-term patient adherence.

Fundraising Readiness Revenue scale near broad mid-market levels suggests readiness for partnerships or funding rounds to support manufacturing expansion, R&D for biologic crosslinkers, and broadened product portfolio.